Genmab A/S Balance Sheet
NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Genmab A/S financial position
At the end of fiscal 2025, Genmab A/S reported total assets of $12.87 billion, up 100.7% from a year earlier against total liabilities of $7.03 billion. Shareholders' equity stood at $5.85 billion, or 45.4% of assets. The company held $1.72 billion in cash and equivalents against $5.27 billion of debt, a net debt position of $3.56 billion.
The current ratio (current assets divided by current liabilities) was 2.02, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.90.
Summary generated from market data by MetaCap's automated system. Methodology
Genmab A/S balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 1.72B | 1.38B | 2.20B |
| Receivables | 1.11B | 923.00M | 733.00M |
| Inventory | 18.00M | 9.00M | 8.00M |
| Total Current Assets | 2.88B | 3.90B | 4.91B |
| Property, Plant & Equipment | 153.00M | 137.00M | 142.00M |
| Goodwill | 355.00M | 355.00M | 0 |
| Intangible Assets | 9.12B | 1.73B | 15.00M |
| Total Assets | 12.87B | 6.41B | 5.23B |
| Short-Term Debt | 273.00M | 0 | 0 |
| Total Current Liabilities | 1.43B | 744.00M | 368.00M |
| Long-Term Debt | 5.00B | 0 | 0 |
| Total Liabilities | 7.03B | 1.28B | 545.00M |
| Shareholders' Equity | 5.85B | 5.14B | 4.69B |
| Retained Earnings | 4.10B | 3.39B | 2.74B |
| Total Debt | 5.27B | 0 | 0 |
| Net Cash (Debt) | -3.56B | 1.38B | 2.20B |
| Shares Outstanding | 64.24M | 66.19M | 66.07M |
This table shows 3 annual periods of Genmab A/S's balance sheet, from FY 2025 back to FY 2023, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow GMAB's reporting calendar. What is a balance sheet?